Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company has developed and commercialized a patented series of amphiphilic poly-glucosamine derivatives ("Emine®" series), which function as moisturizing, water-holding, emollient, barrier-forming agents in skin and hair care. These polymers combine hydrophilic glucosamine with lipophilic fatty acids to create unique properties such as moisture retention and antibacterial effects. The Emine® series is used by OEM/ODM partners in various functional cosmetic formulations. No clinical trial data is relevant since these are not drugs but cosmetic ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Institute for Novel Natural-Materials.